Cargando…

Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer

Androgen receptor (AR) antagonist MDV3100 is the first therapeutic approach in treating castration-resistant prostate cancer (CRPC), but tumours frequently become drug resistant via multiple mechanisms including AR amplification and mutation. Here we identify the small molecule Ailanthone (AIL) as a...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yundong, Peng, Shihong, Wang, Jinhua, Chen, Huang, Cong, Xiaonan, Chen, Ang, Hu, Meichun, Qin, Min, Wu, Haigang, Gao, Shuman, Wang, Liguo, Wang, Xin, Yi, Zhengfang, Liu, Mingyao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159881/ https://www.ncbi.nlm.nih.gov/pubmed/27959342 http://dx.doi.org/10.1038/ncomms13122

Ejemplares similares

Ailanthone: a new potential drug for castration-resistant prostate cancer
por: Peng, Shihong, et al.
Publicado: (2017)

Enzalutamide (formerly MDV3100) prolongs survival in docetaxel-pretreated castration-resistant prostate cancer patients
por: Heck, Matthias M., et al.
Publicado: (2013)

Regression of Castration-Resistant Prostate Cancer by a Novel Compound HG122
por: Cong, Xiaonan, et al.
Publicado: (2021)

Influence of Androgen Receptor Antagonist MDV3100 Therapy on Rats With Benign Prostatic Hyperplasia
por: Yang, Minggen, et al.
Publicado: (2021)

Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer
por: Hu, Meichun, et al.
Publicado: (2015)

Abiraterone and MDV3100 inhibits the proliferation and promotes the apoptosis of prostate cancer cells through mitophagy
por: Han, Jingli, et al.
Publicado: (2019)

Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells
por: Wang, Quan, et al.
Publicado: (2018)

A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer
por: Wang, Jinhua, et al.
Publicado: (2019)

Ailanthone: A novel potential drug for treating human cancer
por: Ding, Haixiang, et al.
Publicado: (2020)

HDAC inhibitors with potential to overcome drug resistance in castration-resistant prostate cancer
por: Biersack, Bernhard, et al.
Publicado: (2022)

Temporal transcriptome changes induced by MDV in marek's disease-resistant and -susceptible inbred chickens
por: Yu, Ying, et al.
Publicado: (2011)

Adaptive pathways and emerging strategies overcoming treatment resistance in castration resistant prostate cancer
por: Armstrong, Cameron M., et al.
Publicado: (2016)

Exploration of Alternative Splicing (AS) Events in MDV-Infected Chicken Spleens
por: Wang, Lulu, et al.
Publicado: (2021)

Ailanthone induces autophagic and apoptotic cell death in human promyelocytic leukemia HL-60 cells
por: Wei, Cheng, et al.
Publicado: (2018)

Ailanthone Induces Cell Cycle Arrest and Apoptosis in Melanoma B16 and A375 Cells
por: Liu, Wenjing, et al.
Publicado: (2019)

Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer
por: Moon, Sue Jin, et al.
Publicado: (2021)

Selective androgen receptor degrader (SARD) to overcome antiandrogen resistance in castration-resistant prostate cancer
por: Wu, Meng, et al.
Publicado: (2023)

Ailanthone Inhibits Proliferation, Migration and Invasion of Osteosarcoma Cells by Downregulating the Serine Biosynthetic Pathway
por: Zhang, Yawen, et al.
Publicado: (2022)

Is the U(3100) strange diquonium?
por: Siebert, Hans-Wolfgang
Publicado: (1987)

SOX8 Knockdown Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting the Notch Signaling Pathway
por: Du, Zhongbo, et al.
Publicado: (2022)

Targeting Pyruvate Carboxylase by a Small Molecule Suppresses Breast Cancer Progression
por: Lin, Qingxiang, et al.
Publicado: (2020)

Selective degradation of AR-V7 to overcome castration resistance of prostate cancer
por: Liu, Yuan, et al.
Publicado: (2021)

Ailanthone Inhibits Cell Proliferation in Tongue Squamous Cell Carcinoma via PI3K/AKT Pathway
por: Wang, Shuhan, et al.
Publicado: (2022)

Antitumor Action of a Novel Histone Deacetylase Inhibitor, YF479, in Breast Cancer()
por: Zhang, Tao, et al.
Publicado: (2014)

U(S)3 Serine/Threonine Protein Kinase from MDV-1, MDV-2, and HVT Differentially Regulate Viral Gene Expression and Replication
por: Liao, Yifei, et al.
Publicado: (2021)

AMD3100/CXCR4 Inhibitor
por: De Clercq, Erik
Publicado: (2015)

Hypoxia‐inducible factor 1A inhibition overcomes castration resistance of prostate tumors
por: Terzic, Julie, et al.
Publicado: (2023)

Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer
por: Zhao, Jingwen, et al.
Publicado: (2016)

Physiological and Transcriptomic Analysis of Arabidopsis thaliana Responses to Ailanthone, a Potential Bio-Herbicide
por: Hopson, Chantz Allen, et al.
Publicado: (2022)

ASFV transcription reporter screening system identifies ailanthone as a broad antiviral compound
por: Zhang, Yuhang, et al.
Publicado: (2023)

Mapping QTL Associated with Resistance to Avian Oncogenic Marek’s Disease Virus (MDV) Reveals Major Candidate Genes and Variants
por: Smith, Jacqueline, et al.
Publicado: (2020)

The Role of Dendritic Cells in the Host Response to Marek’s Disease Virus (MDV) as Shown by Transcriptomic Analysis of Susceptible and Resistant Birds
por: Chakraborty, Pankaj, et al.
Publicado: (2022)

Data on meq gene sequence analysis of Ludhiana MDV isolates
por: Gupta, Mridula, et al.
Publicado: (2016)

Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling
por: Lin, T-H, et al.
Publicado: (2013)

The operation of Luciole on-line to a CDC 3100
por: Blackall, P M, et al.
Publicado: (1966)

Nikon D3100 digital field guide
por: Thomas, J Dennis
Publicado: (2011)

Ailanthone Inhibits Huh7 Cancer Cell Growth via Cell Cycle Arrest and Apoptosis In Vitro and In Vivo
por: Zhuo, Zhenjian, et al.
Publicado: (2015)

The CXCR4 Antagonist, AMD3100, Reverses Mesenchymal Stem Cell-Mediated Drug Resistance in Relapsed/Refractory Acute Lymphoblastic Leukemia
por: Wang, Shan, et al.
Publicado: (2020)

The Emergence of a vv + MDV Can Break through the Protections Provided by the Current Vaccines
por: Shi, Meng-ya, et al.
Publicado: (2020)

Structural characteristics and antiviral activity of multiple peptides derived from MDV glycoproteins B and H
por: Wang, Xiaojia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_peb8n1pk0ks4muqv13qijjo3i6